| Structure | Chemical Name | CAS | MF |
|
FadA protein
|
|
|
|
|
FADD AGAROSE
|
|
|
|
|
FADCP
|
|
|
|
|
FADD HUMAN
|
|
|
|
|
FAC-MV protocol
|
|
|
|
|
FACP protocol
|
|
|
|
|
FAC1 protein
|
|
|
|
|
fac-ReBr(CO)3bis(bis(hydroxymethyl)phosphino)ethane
|
|
|
|
|
fac-ReBr(CO)3-bis(bis(hydroxymethyl)phosphino)benzene
|
|
|
|
|
FACSIMILEMACHINEFUME
|
|
|
|
|
Facteur thymique serique
|
78922-62-0
|
C33H54N12O15
|
|
|
FADIP protocol
|
|
|
|
|
F-actin-binding proteins
|
|
|
|
|
Factice
|
12653-61-1
|
|
|
|
factor VIII,recoMbinant
|
|
|
|
|
factor Xa, Glu-Gly-Arg-
|
|
|
|
|
factor X San Antonio
|
|
|
|
|
factor XII Locarno
|
|
|
|
|
factor V clotting antigen
|
|
|
|
|
factor III(Glc)
|
|
|
|
|
factor XII Bern
|
|
|
|
|
factor IX Chongqing
|
|
|
|
|
factor X Vorarlberg
|
|
|
|
|
factor H-related protein 2
|
|
|
|
|
factor EF-P
|
|
|
|
|
factor H-related protein 4
|
|
|
|
|
factor IX Nagoya 3
|
|
|
|
|
factor XII Washington D.C.
|
|
|
|
|
Factor XIIa
|
|
|
|
|
factor X Nottingham
|
|
|
|
|
factor X Kanazawa
|
|
|
|
|
factor H-related protein p39
|
|
|
|
|
factor VIII receptor
|
|
|
|
|
factor V receptor
|
|
|
|
|
factor IX Milano
|
|
|
|
|
factor IX Madrid
|
|
|
|
|
factor IX Kawachinagano
|
|
|
|
|
factor IX Niigata
|
103289-50-5
|
|
|
|
factor IX Zutphen
|
|
|
|
|
factor IX Cardiff
|
|
|
|
|
factor X receptor
|
|
|
|
|
factor VII related antigen
|
|
|
|
|
factor J
|
|
|
|
|
factor H receptor
|
|
|
|
factor XIIIb
|
97089-56-0
|
C15H23N5O7S
|
|
|
factor V Cambridge
|
|
|
|
|
factor IX (1-47)
|
|
|
|
|
factor IX Strasbourg 2
|
|
|
|
|
factor XIIa inhibitor
|
|
|
|
|
factor XIII subunit A
|
104641-95-4
|
|
|
|
factor IX Lincoln Park
|
|
|
|
factor 390 A
|
95617-07-5
|
C39H48N10O24P2
|
|
|
factor II clotting antigen
|
|
|
|
|
Factor Xa, des(1-44)-
|
|
|
|
|
factor B-C3b fragment Bb
|
|
|
|
|
factor X Friuli
|
|
|
|
|
factor X activator, Bothrops atrox venom
|
|
|
|
|
factor IX-factor X-binding protein
|
143012-00-4
|
|
|
|
factor IX Cambridge
|
|
|
|
|
factor VIII Ise
|
|
|
|
|
factor IX Seattle(2)
|
|
|
|
|
factor H-related protein 1
|
|
|
|
|
factor IX-binding protein
|
|
|
|
|
factor X Taunton
|
|
|
|
|
factor X-binding protein
|
|
|
|
|
factor V Leiden
|
|
|
|
|
Factor VIII Leiden
|
|
|
|
|
Factor X Stockton
|
|
|
|
|
factor IX Long Beach
|
|
|
|
|
factor IX BM Nagoya
|
|
|
|
factor III, vitamin B 12
|
14708-95-3
|
C61H84CoN14O15P
|
|
|
Factor-42
|
|
|
|
|
factor C
|
|
|
|
|
FACTOR V DEFICIENT PLASMA
|
|
|
|
|
FACTOR VIII DEFICIENT PLASMA
|
|
|
|
|
FACTOR V ACTIVATOR
|
65522-14-7
|
|
|
|
FACTOR X [3H]
|
|
|
|
|
FACTORVII,CLONE:HVII-2,MABANTI-HUMAN
|
|
|
|
|
FACTOR-H:CLONE:OX-24,MABANTI-:FITC
|
|
|
|
|
FACTORIX,RABBITANTI-
|
|
|
|
|
FACTORVIIICOAGULANT,CLONE:24-2-C7,MABANTI-HUMAN
|
|
|
|
|
FACTORVII,CLONE:HVII-1,MABANTI-HUMAN
|
|
|
|
|
FACTORI,ALPHACHAIN,CLONE:061-02,MABANTI-HUMAN:ELISA/WB
|
|
|
|
|
FACTORVIII(SSDOMAIN),360KD&210KD,CLONE:RFFVIIIC/10,MABANTI-HUMAN,SWINE:ELISA/WB
|
|
|
|
|
FACTORI,ALPHACHAIN,CLONE:061-01,MABANTI-HUMAN:ELISA/WB
|
|
|
|
|
FACTORB,BBFRAGMENTCOMPLEMENT,CLONE:008-02,MABANTI-HUMAN:ELISA/WB
|
|
|
|
|
FACTOR-H:CLONE:OX-24,MABANTI-
|
|
|
|
|
FACTORIX,RABBITANTI-HUMAN
|
|
|
|
|
FACTORIX,CHRISTMASFACTOR,DENATURED,CLONE:227-15,MABANTI-HUMAN
|
|
|
|
|
FACTOR-I:CLONE:OX-21,MABANTI-
|
|
|
|
|
FACTORVIII,HUMAN,RECOMBINANT
|
|
|
|
|
FACTORIX,CLONE:HIX-5,MABANTI-HUMAN
|
|
|
|
|
FACTORIX,CHRISTMASFACTOR,DENATURED,CLONE:227-09,MABANTI-HUMAN:ELISA
|
|
|
|
|
FACTORIX,CLONE:HIX-1,MABANTI-HUMAN
|
|
|
|
|
FACTORVII(INHIBITORY),CLONE:RFFVII/1,MABANTI-HUMAN:WB
|
|
|
|
|
FACTORIX,CHRISTMASFACTOR,NATIVE,CLONE:133-09,MABANTI-HUMAN:ELISA/WB
|
|
|
|
|
FACTORVIII,HUMAN
|
|
|
|
|
FACTORVIII(HEAVYCHAIN),360KD&210KD&92KD,CLONE:RFFVIIIC/8,MABANTI-HUMAN:ELISA/WB
|
|
|
|
|
FACTORVIII(HEAVYCHAIN),360KD&210KD&92KD,CLONE:RFFVIIIC/8,MABANTI-HUMAN,ALP:ELISA/WB
|
|
|
|
|
FACTORBCOMPLEMENT,CLONE:008-04,MABANTI-HUMAN:ELISA/WB
|
|
|